An FDA warning letter to Dr. Reddy's Laboratories ( $RDY ) shows that inspectors found many of the data manipulation issues and contamination concerns that have landed many of India's top drugmakers in trouble. But most troubling to the agency was ... FiercePharma, 23 hours ago
Dr Reddy's Lab shares fall over 13 per cent on USFDA warning - The Weather Space, 2 weeks ago
Sun Pharma, Dr. Reddy's Lab Shares Slump on Compliance Worries - NDTV, 2 weeks ago
In 2008, Japanese firm Daiichi Sankyo had bought out the country's largest drug maker Ranbaxy for USD 4.6 billion.(Reuters) The government is likely to commission a study soon to assess the impact of foreign direct investment in existing ...Financial Express, 1 month ago Indian Government Decides to Assess the Impact of FDI in Pharma Companies MedIndia, 1 month ago
Sun Pharmaceutical 's buyout of troubled Ranbaxy Laboratories this year came with the chore of facing the issues that led the FDA to ban four Ranbaxy plants in India. But now Sun finds itself cleaning up a mess from Ranbaxy's U.S. manufacturing ...FiercePharmaManufacturing, 4 weeks ago
Mr Choksey says housing finance and auto stocks can gain from the recommendations of seventh Pay Commission. Indian stock markets have witnessed a sharp correction over the last few months amid a selloff by foreign investors ahead of the ...NDTV, 1 day ago
The fall in market capitalization of India's top five pharma firms can be attributed to warnings and import alerts issued by US FDA on their manufacturing plants Reghu BalakrishnanRavindra Sonavane Market capitalization of India's top five ...Livemint.com, 1 week ago R&D spending of 25 India pharma cos soar by 28.8% in 2014-15 PharmaBiz, 1 month ago
Dive Brief: Sun Pharma is reportedly in talks to buya Japan-branded portfolio from Novartis. The deal, which is potentially in the $400 million range, could be completed by December. No Indian companies have entered the Japanese biopharma market ...BioPharma Dive, 1 week ago
In the fourth episode of first season of Satyamev Jayate , Aamir Khan spoke about the use of generic medicines. Generic medicines cost less and are a good alternative to branded medicines. Most times, doctors prescribe a medicine and people go to ...Yourstory.in, 1 week ago
Biosimilar market is projected to be worth USD 32 billion worldwide by 2025 According to 'Global Biosimilars Market, 2015-2025'
Dublin, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/b2mt8g/global ) has announced the addition of the "Global Biosimilars Market, 2015 - 2025" report to their offering. Overall, with the ...Franklin Credit Management Corporation, 1 week ago
By Chiranjivi Chakraborty NEW DELHI: Pharmaceutical stocks have suddenly become very volatile in the market in the past month. Industry heavyweights Sun Pharma and Dr Reddy's Labs have been facing difficulties as the US drug regulator has tightened ...Economic Times, 2 weeks ago
Global Biosimilars Market Report, 2015-2025 - The biosimilar market is projected to be worth USD 32 billion worldwide by 2025
DUBLIN , Nov. 03, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hcv3cc/global ) has announced the addition of the "Global Biosimilars Market, 2015 - 2025" report to their offering. Characterised by ...Ulitzer, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!